Screening
For women who are not at increased risk of developing ovarian cancer, tests such as pelvic examination, tests for CA125 (a cancer biomarker found in the blood) or other biomarkers, ultrasound (including transvaginal ultrasound) or a combination of these do not reduce mortality from ovarian cancer.
Ovarian cancer screening or surveillance is not recommended for women at high or potentially high risk of ovarian cancer. If a woman is found to have a gene fault that increases her risk, she may want to consider risk-reducing surgery. The most effective risk-reducing strategy is removal of both ovaries and fallopian tubes (bilateral salpingo-oophorectomy).